3D Diagnostic has successful first day on stock exchange
3D Diagnostic Imaging had a successful debut day on the AIM (Alternative Investment Market) yesterday.
The Scottish company, which is becoming increasingly well-known as a result of interest in its CarieScan product, enjoyed a profitable day, with its value on the stock market increasing by a third during the day. The value of the company rose from 10.3 million pounds to 15.3 million pounds.
The cash generated from stock market exchanging will be used to promote the CarieScan product in America. 3D Diagnostic has already signed a huge deal with Patterson Dental, a major distributor in the USA and Canada and is hoping to succeed in other international markets. The company has announced that it will soon appoint ten representatives to work in North America.
The CarieScan is a state of the art piece of dental equipment, which can be used to identify early warning signs of decay; the device uses technology developed by teams at St Andrew’s University and Dundee University to measure bone density. The CarieScan also uses Bluetooth technology, which enables dentists to send the information from the device straight to their computer.
Join this Discussion